Article Details

Celldex Presents Positive Preclinical Data from PD-1/ILT4 Bispecific Antibody Program CDX ...

Retrieved on: 2021-11-13 15:36:40

Tags for this article:

Click the tags to see associated articles and topics

Celldex Presents Positive Preclinical Data from PD-1/ILT4 Bispecific Antibody Program CDX .... View article details on hiswai:

Excerpt

About Celldex Therapeutics, Inc. Celldex is a clinical stage biotechnology company dedicated to developing monoclonal and bispecific antibodies that ...

Article found on: www.biospace.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up